Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 1
2014 1
2015 2
2016 6
2017 5
2018 6
2019 10
2020 13
2021 11
2022 11
2023 9
2024 15
2025 16
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.
Sajadi MM, Abbasi A, Tehrani ZR, Siska C, Clark R, Chi W, Seaman MS, Mielke D, Wagh K, Liu Q, Jumpa T, Ketchem RR, Nguyen DN, Tolbert WD, Pierce BG, Atkinson B, Deming D, Sprague M, Asakawa A, Ferrer D, Dunn Y, Calvillo S, Yin R, Guest JD, Korber B, Mayer BT, Sato AH, Ouyang X, Foulke S, Habibzadeh P, Karimi M, Aslanabadi A, Hojabri M, Saadat S, Zareidoodeji R, Kędzior M, Pozharski E, Heredia A, Chen H, Montefiori D, Ferrari G, Pazgier M, Lewis GK, Jardine JG, Lusso P, DeVico A. Sajadi MM, et al. Among authors: karimi m. Structure. 2025 Jul 3;33(7):1150-1164.e8. doi: 10.1016/j.str.2025.04.016. Epub 2025 May 14. Structure. 2025. PMID: 40373766 Free PMC article.
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial.
Rousseau A, Karimi M, Michiels S, Roubaud G, Maldonado X, Supiot S, McDermott R, Flechon A, Tombal B, Ronchin P, Berthold D, Berdah JF, Kacso G, Gravis G, Calabro F, Tartas S, Muracciole X, Ribault H, Fizazi K, Foulon S. Rousseau A, et al. Among authors: karimi m. Eur J Cancer. 2025 Nov 17;230:116024. doi: 10.1016/j.ejca.2025.116024. Epub 2025 Sep 27. Eur J Cancer. 2025. PMID: 41045691 Clinical Trial.
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.
Hamza A, Gestraud P, Karimi M, Tran-Dien A, Syx L, Vacher S, Peretti Q, Lacroix L, Attignon V, Soubeyran I, Jézéquel P, Planchard D, Melaabi S, Dailey-Chwalibóg T, Jimenez M, Michiels S, Servant N, Le Tourneau C, Girard N, André F, Besse B, Kamal M, Barlesi F, Bièche I. Hamza A, et al. Among authors: karimi m. Br J Cancer. 2025 Nov;133(10):1554-1564. doi: 10.1038/s41416-025-03183-2. Epub 2025 Sep 11. Br J Cancer. 2025. PMID: 40931129
Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohort.
Fraslin A, Colrat F, Karimi M, Bonastre J, Groussard K, Teitsson S, Prudent A, Branchoux S, Radvanyi F, Benhamou S, Allory Y, Lebret T. Fraslin A, et al. Among authors: karimi m. BMC Urol. 2025 May 12;25(1):120. doi: 10.1186/s12894-025-01792-w. BMC Urol. 2025. PMID: 40355842 Free PMC article.
Geographic differences in exposures to metals and essential elements in pregnant women living in Suriname.
Abdoel Wahid FZ, Hindori-Mohangoo AD, Covert HH, Karimi M, Sabrin S, Shafer M, Gokoel AR, Shankar A, Zijlmans W, Lichtveld M, Wickliffe JK. Abdoel Wahid FZ, et al. Among authors: karimi m. J Expo Sci Environ Epidemiol. 2023 Nov;33(6):911-920. doi: 10.1038/s41370-023-00526-0. Epub 2023 Feb 10. J Expo Sci Environ Epidemiol. 2023. PMID: 36765100 Free PMC article.
107 results